12:00 AM
 | 
Apr 15, 2013
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Etubics preclinical data

In mice with HPV-expressing tumors, Etubic's HPV 16 E6/E7 vaccine plus cisplatin and radiation significantly improved survival vs. null vector-treated controls...

Read the full 84 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >